Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
HBIO compared with A: revenue, margins and what each company keeps, and the suppliers and customers both name
HBIO
Harvard Bioscience Inc
Change
Mkt cap
Revenue
Revenue
A
Agilent Technologies, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
HBIO
Harvard Bioscience Inc
vs
A
Agilent Technologies, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
HBIO
Harvard Bioscience Inc
Change
8.61
▲
+0.12%
· post 8.50
Mkt cap
$39.5M
Revenue
$23M
Q2 FY26
Revenue
$87M
FY25
A
Agilent Technologies, Inc.
Change
175.74
▲
+2.18%
· post 175.99
Closed
Nov 3 '26
Mkt cap
$48.5B
Revenue
$1.9B
Q3 FY26
Revenue
$6.9B
FY25
vs
Compare
Closed
Nov 3 '26
HBIO
Harvard Bioscience Inc
vs
A
Agilent Technologies, Inc.
8.61
▲
+0.12%
post 8.50
Price
175.74
▲
+2.18%
post 175.99
$39.5M
Mkt cap
$48.5B
Q2 FY26
$23M
Revenue
$1.9B
Q3 FY26
FY25
$87M
Revenue
$6.9B
FY25
Change
Change
HBIO
8.61
▲
+0.12%
vs
A
175.74
▲
+2.18%
Closed
Nov 3 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
HBIO, solid
A, dashed
Supply-chain overlap
Revenue flow
HBIO: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only HBIO
1
—
Harvard University
unlisted
supplier
Shared
0
No shared counterparties.
Only A
2
ALNY
Alnylam Pharmaceuticals
customer
WGS
GeneDx
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR